1. Home
  2. Analysis
  3. Promethegan
  4. Levetiracetam

Promethegan and Levetiracetam drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Promethegan and Levetiracetam. Common interactions include conjunctivitis among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people who take Promethegan and Levetiracetam have. It is created by eHealthMe based on reports of 18 people who take Promethegan and Levetiracetam from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 27, 2023

18 people who take Promethegan and Levetiracetam together, and have interactions are studied.

What is Promethegan?

Promethegan has active ingredients of promethazine hydrochloride. It is often used in nausea. eHealthMe is studying from 405 Promethegan users for its effectiveness, alternative drugs and more.

What is Levetiracetam?

Levetiracetam has active ingredients of levetiracetam. It is often used in epilepsy. eHealthMe is studying from 60,637 Levetiracetam users for its effectiveness, alternative drugs and more.

Number of Promethegan and Levetiracetam reports submitted per year:

Promethegan and Levetiracetam drug interactions.

Common Promethegan and Levetiracetam drug interactions by gender *:

female:

  1. Conjunctivitis
  2. Hypersensitivity
  3. Orbital oedema
  4. Pneumomediastinum
  5. Pneumothorax
  6. Sepsis
  7. Subcutaneous emphysema

male:

  1. Chronic kidney disease
  2. Anhedonia
  3. Dysstasia
  4. Osteopenia
  5. Osteoporosis
  6. Renal disorder
  7. Rib fracture
  8. Spinal fracture
  9. Alcoholic seizure
  10. Bone disorder

Common Promethegan and Levetiracetam drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Anhedonia
  2. Anxiety
  3. Bone density decreased
  4. Dementia
  5. Dysstasia
  6. Emotional distress
  7. Osteopenia
  8. Osteoporosis
  9. Pain
  10. Renal disorder

40-49:

n/a

50-59:

  1. Emotional distress
  2. Pain
  3. Renal failure
  4. Bone metabolism disorder
  5. Alcoholic seizure
  6. Bone disorder
  7. Conjunctivitis
  8. Hypersensitivity
  9. Orbital oedema
  10. Pneumomediastinum

60+:

  1. Anhedonia
  2. Anxiety
  3. Chronic kidney disease
  4. Emotional distress
  5. Pain
  6. Renal failure

Common conditions people have *:

  1. Hiv Infection: 15 people, 83.33%
  2. Stress And Anxiety: 1 person, 5.56%
  3. Pain: 1 person, 5.56%
  4. Insomnia (sleeplessness): 1 person, 5.56%
  5. Headache (pain in head): 1 person, 5.56%
  6. Colon Cancer: 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Promethegan and Levetiracetam?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Promethegan and Levetiracetam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Levetiracetam side effects:

Browse all side effects of Levetiracetam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Levetiracetam interactions:

Browse all interactions between Levetiracetam and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on promethazine hydrochloride and levetiracetam (the active ingredients of Promethegan and Levetiracetam, respectively), and Promethegan and Levetiracetam (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Promethegan and Levetiracetam.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.